Exclusive Webinar:
Unlock Your Body’s Potential with SVF Therapy

(Fat-Derived Regenerative Therapy)

Discover how Stromal Vascular Fraction (SVF) Therapy, offered exclusively through our sister company Avastar® in collaboration with CellMark 360, may support your body’s natural ability to restore and revitalize.

📅 Date: Wednesday, Sept. 10, at 6 PM

Learn More About Stromal Vascular Fraction (SVF) Therapy

During the Webinar, You’ll Learn:

  • How Fat-Derived Regenerative Therapy works and why it’s different from other options.
  • The latest scientific research supporting its safety and success rates.
  • Which types of patients and conditions may benefit most from SVF.
  • What the process looks like from initial consultation to treatment and what you can expect afterward.

Spots Are Limited
Reserve Yours Today

This free webinar is your opportunity to explore a cutting-edge regenerative therapy, understand how it may fit your health goals, and get your questions answered live by our expert team.

SVF Webinar
Terms and Conditions

What is SVF Therapy?

SVF Therapy is an advanced regenerative approach that uses a small portion of your own fat tissue to isolate a concentrated mix of regenerative cells including mesenchymal stromal cells (MSCs) and growth factors.

These cells are then re-introduced into targeted areas to help support the body’s natural restoration processes.

Why it matters:

  • Minimally manipulated
  • Homologous use
  • FDA compliant

Why Choose Avastar® for SVF Therapy?

This advanced therapy is offered exclusively at Tyrance Orthopedics & Sports Medicine through our sister company, Avastar®, powered by CellMark 360.

With state-of-the-art technology and a commitment to the highest safety standards, we bring you an innovative, patient-focused approach you won’t find anywhere else in the region.

Who Can Benefit from SVF Therapy?

  • Joint discomfort (knees, shoulders, hips)
  • Soft tissue injuries (ligaments, tendons)
  • Degenerative musculoskeletal conditions
  • Inflammatory orthopedic concerns